Literature DB >> 30333170

Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States.

Kristen M Ogden1,2, Yi Tan3,4, Asmik Akopov4, Laura S Stewart5, Rendie McHenry5, Christopher J Fonnesbeck6, Bhinnata Piya5, Maximilian H Carter5, Nadia B Fedorova4, Rebecca A Halpin4, Meghan H Shilts3, Kathryn M Edwards5, Daniel C Payne7, Mathew D Esona7, Slavica Mijatovic-Rustempasic7, James D Chappell5, John T Patton8, Natasha B Halasa5, Suman R Das9,3,4.   

Abstract

Rotavirus is the leading global cause of diarrheal mortality for unvaccinated children under 5 years of age. The outer capsid of rotavirus virions consists of VP7 and VP4 proteins, which determine viral G and P types, respectively, and are primary targets of neutralizing antibodies. Successful vaccination depends upon generating broadly protective immune responses following exposure to rotaviruses presenting a limited number of G- and P-type antigens. Vaccine introduction resulted in decreased rotavirus disease burden but also coincided with the emergence of uncommon G and P genotypes, including G12. To gain insight into the recent predominance of G12P[8] rotaviruses in the United States, we evaluated 142 complete rotavirus genome sequences and metadata from 151 clinical specimens collected in Nashville, TN, from 2011 to 2013 through the New Vaccine Surveillance Network. Circulating G12P[8] strains were found to share many segments with other locally circulating strains but to have distinct constellations. Phylogenetic analyses of G12 sequences and their geographic sources provided evidence for multiple separate introductions of G12 segments into Nashville, TN. Antigenic epitopes of VP7 proteins of G12P[8] strains circulating in Nashville, TN, differ markedly from those of vaccine strains. Fully vaccinated children were found to be infected with G12P[8] strains more frequently than with other rotavirus genotypes. Multiple introductions and significant antigenic mismatch may in part explain the recent predominance of G12P[8] strains in the United States and emphasize the need for continued monitoring of rotavirus vaccine efficacy against emerging rotavirus genotypes.IMPORTANCE Rotavirus is an important cause of childhood diarrheal disease worldwide. Two immunodominant proteins of rotavirus, VP7 and VP4, determine G and P genotypes, respectively. Recently, G12P[8] rotaviruses have become increasingly predominant. By analyzing rotavirus genome sequences from stool specimens obtained in Nashville, TN, from 2011 to 2013 and globally circulating rotaviruses, we found evidence of multiple introductions of G12 genes into the area. Based on sequence polymorphisms, VP7 proteins of these viruses are predicted to present themselves to the immune system very differently than those of vaccine strains. Many of the sick children with G12P[8] rotavirus in their diarrheal stools also were fully vaccinated. Our findings emphasize the need for continued monitoring of circulating rotaviruses and the effectiveness of the vaccines against strains with emerging G and P genotypes.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  G12P[8]; efficacy; genotype; phylogenetics; rotavirus; vaccine

Mesh:

Substances:

Year:  2018        PMID: 30333170      PMCID: PMC6288334          DOI: 10.1128/JVI.01476-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  91 in total

Review 1.  Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs.

Authors:  Krisztián Bányai; Brigitta László; Jazmin Duque; A Duncan Steele; E Anthony S Nelson; Jon R Gentsch; Umesh D Parashar
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

2.  VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans.

Authors:  Nitya Nair; Ningguo Feng; Lisa K Blum; Mrinmoy Sanyal; Siyuan Ding; Baoming Jiang; Adrish Sen; John M Morton; Xiao-Song He; William H Robinson; Harry B Greenberg
Journal:  Sci Transl Med       Date:  2017-06-21       Impact factor: 17.956

3.  Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM.

Authors:  James Z Chen; Ethan C Settembre; Scott T Aoki; Xing Zhang; A Richard Bellamy; Philip R Dormitzer; Stephen C Harrison; Nikolaus Grigorieff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

4.  Rotavirus architecture at subnanometer resolution.

Authors:  Zongli Li; Matthew L Baker; Wen Jiang; Mary K Estes; B V Venkataram Prasad
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

5.  Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread.

Authors:  Jelle Matthijnssens; Elisabeth Heylen; Mark Zeller; Mustafizur Rahman; Philippe Lemey; Marc Van Ranst
Journal:  Mol Biol Evol       Date:  2010-06-03       Impact factor: 16.240

6.  Rotavirus.

Authors:  Manuel A Franco; Harry B Greenberg
Journal:  Microbiol Spectr       Date:  2013-12

7.  Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua.

Authors:  Filemón Bucardo; Christine M Rippinger; Lennart Svensson; John T Patton
Journal:  Infect Genet Evol       Date:  2012-04-02       Impact factor: 3.342

8.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

9.  Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis.

Authors:  Maria Hemming; Timo Vesikari
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

10.  Emergence of human G2P[4] rotaviruses containing animal derived gene segments in the post-vaccine era.

Authors:  Mark Zeller; Valerie Nuyts; Elisabeth Heylen; Sarah De Coster; Nádia Conceição-Neto; Marc Van Ranst; Jelle Matthijnssens
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

View more
  12 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  The 13th International Double-Stranded RNA Virus Symposium, Houffalize, Belgium, 24 to 28 September 2018.

Authors:  Ulrich Desselberger
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1.

Authors:  Annika Skansberg; Molly Sauer; Marissa Tan; Mathuram Santosham; Mary Carol Jennings
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

4.  Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.

Authors:  Yuta Kanai; Misa Onishi; Takahiro Kawagishi; Pimfhun Pannacha; Jeffery A Nurdin; Ryotaro Nouda; Moeko Yamasaki; Tina Lusiany; Pattara Khamrin; Shoko Okitsu; Satoshi Hayakawa; Hirotaka Ebina; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

5.  Infection status and circulating strains of rotaviruses in Chinese children younger than 5-years old from 2011 to 2018: systematic review and meta-analysis.

Authors:  Jingxin Li; Hong Wang; Dandi Li; Qing Zhang; Na Liu
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

6.  Comparative genomic analysis of genogroup 1 and genogroup 2 rotaviruses circulating in seven US cities, 2014-2016.

Authors:  Mathew D Esona; Rashi Gautam; Eric Katz; Jose Jaime; M Leanne Ward; Mary E Wikswo; Naga S Betrapally; Slavica M Rustempasic; Rangaraj Selvarangan; Christopher J Harrison; Julie A Boom; Jan Englund; Eileen J Klein; Mary Allen Staat; Monica M McNeal; Natasha Halasa; James Chappell; Geoffrey A Weinberg; Daniel C Payne; Umesh D Parashar; Michael D Bowen
Journal:  Virus Evol       Date:  2021-03-12

7.  Group A rotavirus surveillance before vaccine introduction in Italy, September 2014 to August 2017.

Authors:  Giovanni Ianiro; Roberto Micolano; Ilaria Di Bartolo; Gaia Scavia; Marina Monini
Journal:  Euro Surveill       Date:  2019-04

8.  Rotavirus symptomatic infection among unvaccinated and vaccinated children in Valencia, Spain.

Authors:  Raúl Pérez-Ortín; Cristina Santiso-Bellón; Susana Vila-Vicent; Noelia Carmona-Vicente; Jesús Rodríguez-Díaz; Javier Buesa
Journal:  BMC Infect Dis       Date:  2019-11-27       Impact factor: 3.090

9.  Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains.

Authors:  Asma Sadiq; Nazish Bostan
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

10.  Novel antigen panel for modern broad-spectrum recombinant rotavirus A vaccine.

Authors:  Olga A Kondakova; Peter A Ivanov; Oleg A Baranov; Ekaterina M Ryabchevskaya; Marina V Arkhipenko; Eugene V Skurat; Ekaterina A Evtushenko; Nikolai A Nikitin; Olga V Karpova
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.